First National Bank of Mount Dora’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Sell
7,194
-17
-0.2% -$7.53K 0.72% 49
2026
Q1
$3.22M Buy
7,211
+999
+16% +$466K 0.7% 54
2025
Q4
$2.82M Buy
6,212
+37
+0.6% +$15.9K 0.62% 50
2025
Q3
$2.42M Sell
6,175
-1,116
-15% -$466K 0.54% 52
2025
Q2
$3.25M Sell
7,291
-58
-0.8% -$26.7K 0.73% 49
2025
Q1
$3.56M Sell
7,349
-4,882
-40% -$2.28M 0.87% 43
2024
Q4
$4.93M Buy
12,231
+352
+3% +$163K 1.15% 35
2024
Q3
$5.52M Buy
11,879
+2,998
+34% +$1.44M 1.25% 29
2024
Q2
$4.16M Buy
8,881
+2,272
+34% +$986K 1% 39
2024
Q1
$2.76M Buy
+6,609
New +$2.79M 0.67% 56

Other funds holding VRTX

First National Bank of Mount Dora's VRTX Position: Q2 2026 in Review

First National Bank of Mount Dora reduced its Vertex Pharmaceuticals (VRTX) stake by 0.24% in Q2 2026, selling an estimated $7.53K and leaving 7,194 shares worth $3.57M. The position accounts for 0.72% of the portfolio, ranked #49.

First National Bank of Mount Dora first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.52M in Q3 2024. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • First National Bank of Mount Dora held 7,194 shares of Vertex Pharmaceuticals worth $3.57M as of Q2 2026.
  • First National Bank of Mount Dora sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
  • Vertex Pharmaceuticals made up 0.72% of First National Bank of Mount Dora's portfolio in Q2 2026, its #49 holding.
  • First National Bank of Mount Dora first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • First National Bank of Mount Dora's Vertex Pharmaceuticals position peaked at $5.52M in Q3 2024.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First National Bank of Mount Dora's 13F filing for Q2 2026, filed 8 Jul 2026.